FDA MedWatch - Eclectic Institute Dietary Supplements: Recall - Possible Salmonella Contamination

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch - Eclectic Institute Dietary Supplements: Recall - Possible Salmonella Contamination
MedWatch logoMedWatch - The FDA Safety Information and Adverse Event Reporting Program

Eclectic Institute Dietary Supplements: Recall - Possible Salmonella Contamination

Include the products Gotu Kola (Centella Asiatica), Bladderwrack (Fucus Vesiculosus)


AUDIENCE: Consumer

ISSUE: Eclectic Institute is voluntarily recalling specific lots of its freeze-dried capsules containing Gotu Kola (Centella asiatica) and Bladderwrack (Fucus vesiculosus) capsules because of potential Salmonella contamination.

Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain. In rare circumstances, Salmonella infection can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.

BACKGROUND: Eclectic Institute sold these products to retailers, individuals, and health practitioners throughout the United States. The affected lots of Gotu Kola (Centella asiatica) products were sold from September 14, 2011 to December 14, 2011. The affected lots of Bladderwrack (Fucus vesiculosus) products were sold from July 14, 2011 to December 14, 2011. See the Press Release for affected lot numbers.

RECOMMENDATION: Consumers in possession of any of these voluntarily recalled products are urged to return the product to Eclectic Institute’s headquarters in Sandy, Oregon, for a full refund.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Read the MedWatch safety alert, including a link to the company press release, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm284711.htm


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux